metaraminol has been researched along with Focal Neurologic Deficits in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WATTS, FB | 1 |
| Cantu, RC | 1 |
| Ames, A | 1 |
| Di Giacinto, G | 1 |
| Dixon, J | 1 |
2 other studies available for metaraminol and Focal Neurologic Deficits
| Article | Year |
|---|---|
MYOCARDIAL INFARCTION, GRAM-NEGATIVE BACTEREMIA, PROLONGED SHOCK, AND LEUKEMOID REACTION.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Bacteremia; Diagnosis; Drug Therapy; Enterobacter ae | 1965 |
Hypotension: a major factor limiting recovery from cerebral ischemia.
Topics: Acidosis; Animals; Epinephrine; Hypotension; Ischemic Attack, Transient; Lactates; Metaraminol; Neur | 1969 |